Chesapeake expands services to meet growing demand

By: Melissa Fassbender
Published in:
June 7, 2017


Jeff Wendel, President and CEO of Chesapeake IRB discusses the growth strategy of Chesapeake IRB and the acquisitions of Institutional Biosafety Corporation and MaGil IRB.

Read Article >

Using Technology to Support NIH Policy

By: Jeffrey Wendel
Published in: Applied Clinical Trials
September 29, 2016

Chesapeake IRB’s president, Jeffrey Wendel, discusses the importance of choosing the right technology to support clinical research trials after the approval of the National Institute of Health’s policy: Use of a Single Institutional Review Board of Record for Multi-Site Research.

Read Article >